BPC-157 takes a broader approach, activating VEGFR2 receptors, suppressing inflammatory cytokines, and boosting fibroblast growth to heal scalp tissue and improve nutrient delivery
Primary research: Visceral fat reduction, lipodystrophy, cognitive function Mechanism: Stimulates pituitary growth hormone release via GHRH receptor activation Regulatory status: FDA-approved (Egrifta) for HIV-associated lipodystrophy Key data: Demonstrated significant visceral adipose tissue reduction and improved cognitive scores in published trials GHK-Cu (Copper Peptide) GHK-Cu is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine
GHK-Cu injectable was included in that restricted category
Researchers study it for fat-cell shrinkage, higher NAD+ levels, and metabolic support without affecting appetite
Some prefer a quick injection before returning to work, while others choose a more complete IV infusion with hydration and supportive vitamins